Nebius Group (NBIS) said it has closed a private offering of convertible senior notes, raising around $4.3B in gross proceeds as the company looks to fund data center build-outs and expand its ...

Nebius (NBIS) stock secures $4.34B in convertible debt to fund AI data centers following $27B Meta deal and $2B Nvidia ...

Convertible notes are agreements where investors lend money to a company, with the expectation that the loan will convert into equity at a later date, usually during the next significant financing ...

Calgary, Alberta / October 15, 2025 –TheNewswire -Credissential Inc. (“Credissential” or the “Company”) (CSE: WHIP), a vertically integrated AI software development companyis pleased to announce a non ...

Nebius Group (NBIS) announced on Wednesday that it has priced an upsized, $4B private offering of convertible senior notes. Shares were fractionally higher in premarket trading. The $4B note offering ...

CHICAGO--(BUSINESS WIRE)--JBT Marel Corporation (NYSE and Nasdaq Iceland: JBTM) announced today that it intends to offer $500 million aggregate principal amount of convertible senior notes due 2030 ...

“We are extremely pleased with the outstanding response to the Convertible Note Offering from high quality institutional investors in the United States, which is a tremendous endorsement of Caledonia ...

(RTTNews) - Mesoblast Limited (MESO, MSB.AX) announced that it has entered into convertible note subscription agreements with SurgCenter principals and existing Mesoblast shareholders, Gregory George ...

Square (NYSE:SQ) plans to offer $1.0B of convertible senior notes due 2025 in a private placement to qualified institutional buyers. Square falls 1.3% in premarket trading. Also expects to grant ...

TOKYO, Japan, July 18, 2025 (GLOBE NEWSWIRE) -- Linkage Global Inc (NASDAQ: LGCB) ("Linkage Global" or the "Company"), a cross-border e-commerce integrated services provider headquartered in Japan, ...

Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced an amendment to ...

JBT Marel Corporation (NYSE and Nasdaq Iceland: JBTM) announced today that it has closed its previously announced private offering (the “Offering”) of $575 million aggregate principal amount of 0.375 ...